E

Eurotech Ltd
OTC:EUOT

Watchlist Manager
Eurotech Ltd
OTC:EUOT
Watchlist
Price: 0 USD Market Closed
Market Cap: $0

Eurotech Ltd
Cash Equivalents

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Eurotech Ltd
Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
E
Eurotech Ltd
OTC:EUOT
Cash Equivalents
$62k
CAGR 3-Years
-79%
CAGR 5-Years
-35%
CAGR 10-Years
N/A
S
Stratos Renewables Corp
OTC:SRNW
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Marimed Inc
OTC:MRMD
Cash Equivalents
$8.9m
CAGR 3-Years
-3%
CAGR 5-Years
24%
CAGR 10-Years
N/A
No Stocks Found

Eurotech Ltd
Glance View

Market Cap
0 USD
Industry
N/A

Eurotech Ltd. operates as a development stage company. The company is headquartered in Manassas, Virginia and currently employs 4 full-time employees. The company went IPO on 2000-09-01. Since its formation, the Company has acquired development and marketing rights to a number of technologies by purchase, assignments and licensing arrangements. Eurotech's business is divided into three divisions: Nuclear and Environmental Technology Solutions, Security and Safeguards (which is conducted through its Markland Technologies, Inc. subsidiary) and Advanced Performance Materials.

EUOT Intrinsic Value
Not Available
E

See Also

What is Eurotech Ltd's Cash Equivalents?
Cash Equivalents
62k USD

Based on the financial report for Mar 31, 2003, Eurotech Ltd's Cash Equivalents amounts to 62k USD.

What is Eurotech Ltd's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
-35%

Over the last year, the Cash Equivalents growth was -88%. The average annual Cash Equivalents growth rates for Eurotech Ltd have been -79% over the past three years , -35% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett